Haemangiomas are the most common tumours of early childhood, affecting up to 10% of infants. Their natural history is very specific, leading to spontaneous resolution in 76% of patients by age of 7 year. Haemangiomas has been considered only a temporary cosmetic defect without an indication for any sort of treatment. On the other hand, many cases of haemangiomas leading to serious or deformity, due to particular location or caused complications. Haemangiomas, complicated by an to ulceration or bleeding, interfering with vital function, or causing a visible or predictable disfigurement are an indication for an early treatment. Treatment of these haemangiomas should be initiated early to prevent further growth and related complications. The method choice depends on numerous factors as child’s age, tumour localization or haemangiomas growth rate. In infants and children surgical treatment is of limited value. Such procedure could be considerate if tumour size allows to its complete resection or for removing of scars and another residual changes. Until recently steroids were the firstline in the treatment in children in complicated haemangiomas. Local steroid therapy is recommended in haemangiomas localized around eyes, nose and mouth. Actually it seems that propranolol plays a major role in treatment of haemangioma. The authors have focused in their review on clinical aspects of application of propranolol in children with haemangiomas presenting current treatment schedules and recommendations.